Short Bowel Syndrome Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1067299
  • December 2021
  • Pharmaceuticals
  • 254 Pages
Report Description

This report is a comprehensive study that examines the Short Bowel Syndrome industry in depth. With reference to key regions and major nations, the study specifies the product type of Short Bowel Syndrome as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Short Bowel Syndrome market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Short Bowel Syndrome market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.

The top vendors and distributors operating in all of the major regions have also been highlighted in the Short Bowel Syndrome market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
 
Short Bowel Syndrome Market Strategic Analysis 

The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Short Bowel Syndrome market study. The market dynamics and factors such as the threat of a Short Bowel Syndrome substitute, the threat of new entrants into the Short Bowel Syndrome market, buyer bargaining power, supplier bargaining power to Short Bowel Syndrome providing companies, and internal rivalry among Short Bowel Syndrome providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.

This analysis assists report users in evaluating the Short Bowel Syndrome market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Short Bowel Syndrome industry.
 
Short Bowel Syndrome Market Key Trends Analysis

The important factors influencing the growth of the Short Bowel Syndrome market have been examined in this report. The driving factors that are boosting demand for Short Bowel Syndromes and the restraining factors that are slowing growth of the Short Bowel Syndrome industry are addressed in depth, as well as their implications for the worldwide Short Bowel Syndrome market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.

Short Bowel Syndrome Market Key Segment Analysis

By segmenting the market by product type, application, and geography, the study provides a clear picture of the Short Bowel Syndrome industry. On the basis of current and future trends, all segments of the Short Bowel Syndrome industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.

The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.

The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
 
Short Bowel Syndrome Market Regional Trends and Market Player’s Analysis

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Short Bowel Syndrome market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Short Bowel Syndrome market throughout the projected period.


 
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Short Bowel Syndrome market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Short Bowel Syndrome market. All important stakeholders in the Short Bowel Syndrome value chain and technological ecosystem are expected to benefit from the insights offered in the Short Bowel Syndrome market research study.

In order to provide a broader understanding of the top competitors in the Short Bowel Syndrome market, the research includes a company market share analysis. Takeda Pharmaceutical Company Limited, Merck KGaA, Zealand Pharma A/S, OxThera, VectivBio AG, 9 Meters Biopharma Inc., Nutrinia Ltd., Hanmi Pharm.Co. Ltd., Pharmascience Inc. are among the major participants in the global Short Bowel Syndrome industry.
 
Scope of the report
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2021
Forecast Period Covered 2021-2028
Units for value Revenue in USD million and CAGR from 2021 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Takeda Pharmaceutical Company Limited, Merck KGaA, Zealand Pharma A/S, OxThera, VectivBio AG, 9 Meters Biopharma Inc., Nutrinia Ltd., Hanmi Pharm.Co. Ltd., Pharmascience Inc.
 
Major Highlights of the Short Bowel Syndrome Market report study:
  • An in-depth examination of the global Short Bowel Syndrome industry will be published soon.
  • The study examines the global Short Bowel Syndrome market and offers major actionable information to its players.
  • The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
  • The report study is expected to aid the industry's key decision-makers in their decision-making process.
  • Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
  • The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Short Bowel Syndrome industry.
  • The Market Ecosystem and Adoption in Different Markets
  • The global Short Bowel Syndrome market is being shaped by several major trends.
  • The size of the Short Bowel Syndrome market in terms of revenue has been measured in the past and will be measured in the future in USD million.
  • Consumer preference patterns and recent industrial developments
  • The worldwide Short Bowel Syndrome market's competitive landscape and player positioning analysis
  • Major players' key goods and solutions, as well as their business strategies
  • Recommendations for new market entrants as well as existing market participants.
  • The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
  • Operating players in the market encounter a number of significant hurdles.
  • An examination of the major risks involved in market operations
 
The report segment of the global Short Bowel Syndrome market as follows:
Global Short Bowel Syndrome Market: By Product Type

  • Hormone
  • Glutamine
  • Others

Global Short Bowel Syndrome Market: By Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales

Global Short Bowel Syndrome Market: By Region
  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:
  • Institutes of research and consulting firms
  • Companies are attempting to get into the Short Bowel Syndrome market.
  • Universities and students
  • Other companies in the Short Bowel Syndrome market include solution providers, product producers, service providers, and others.
  • Private companies and government agencies that are linked
  • Individuals interested in learning more about the Short Bowel Syndrome market

Manufacturers and Segments

  • Takeda Pharmaceutical Company Limited
  • Merck KGaA
  • Zealand Pharma A/S
  • OxThera
  • VectivBio AG
  • 9 Meters Biopharma Inc.
  • Nutrinia Ltd.
  • Hanmi Pharm.Co. Ltd.
  • Pharmascience Inc.
  • Hormone
  • Glutamine
  • Others
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Short Bowel Syndrome Market Snapshot
          2.1.1. Global Short Bowel Syndrome Market By Hormone,2019
               2.1.1.1.
               2.1.1.2.Hormone
               2.1.1.3.Glutamine
          2.1.2. Global Short Bowel Syndrome Market By Hospital Pharmacies,2019
               2.1.2.1.
               2.1.2.2.Hospital Pharmacies
               2.1.2.3.Retail Pharmacies
          2.1.3. Global Short Bowel Syndrome Market By End-use,2019
          2.1.4. Global Short Bowel Syndrome Market By Geography,2019

3. Global Short Bowel Syndrome Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Short Bowel Syndrome Market Size (US$), By Hormone, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Hormone, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Hormone, 2020
     4.2. Global Short Bowel Syndrome Market Size (US$), By Hormone, 2018 – 2028

5. Global Short Bowel Syndrome Market Size (US$), By Hospital Pharmacies, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Hospital Pharmacies, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Hospital Pharmacies, 2020
     5.2. Global Short Bowel Syndrome Market Size (US$), By Hospital Pharmacies, 2018 – 2028

6. Global Short Bowel Syndrome Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Short Bowel Syndrome Market Size (US$), By End-use, 2018 – 2028

7. Global Short Bowel Syndrome Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Short Bowel Syndrome Market Analysis, 2018 – 2028 
          7.2.1. North America Short Bowel Syndrome Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Short Bowel Syndrome Market Size (US$), By Hormone, 2018 – 2028
          7.2.3. North America Short Bowel Syndrome Market Size (US$), By Hospital Pharmacies, 2018 – 2028
          7.2.4. North America Short Bowel Syndrome Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Short Bowel Syndrome Market Analysis, 2018 – 2028 
          7.3.1.  Europe Short Bowel Syndrome Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Short Bowel Syndrome Market Size (US$), By Hormone, 2018 – 2028
          7.3.3. Europe Short Bowel Syndrome Market Size (US$), By Hospital Pharmacies, 2018 – 2028
          7.3.4. Europe Short Bowel Syndrome Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Short Bowel Syndrome Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Short Bowel Syndrome Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Short Bowel Syndrome Market Size (US$), By Hormone, 2018 – 2028
          7.4.3. Asia Pacific Short Bowel Syndrome Market Size (US$), By Hospital Pharmacies, 2018 – 2028
          7.4.4. Asia Pacific Short Bowel Syndrome Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Short Bowel Syndrome Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Short Bowel Syndrome Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Short Bowel Syndrome Market Size (US$), By Hormone, 2018 – 2028
          7.5.3. Latin America Short Bowel Syndrome Market Size (US$), By Hospital Pharmacies, 2018 – 2028
          7.5.4. Latin America Short Bowel Syndrome Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Short Bowel Syndrome Market Analysis, 2018 – 2028 
          7.6.1.  MEA Short Bowel Syndrome Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Short Bowel Syndrome Market Size (US$), By Hormone, 2018 – 2028
          7.6.3. MEA Short Bowel Syndrome Market Size (US$), By Hospital Pharmacies, 2018 – 2028
          7.6.4. MEA Short Bowel Syndrome Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Short Bowel Syndrome Providers
        8.4.1 Takeda Pharmaceutical Company Limited
                8.4.1.1 Business Description
                8.4.1.2 Takeda Pharmaceutical Company Limited Geographic Operations
                8.4.1.3 Takeda Pharmaceutical Company Limited Financial Information
                8.4.1.4 Takeda Pharmaceutical Company Limited Product Positions/Portfolio
                8.4.1.5 Takeda Pharmaceutical Company Limited Key Developments
        8.4.2 Merck KGaA
                8.4.2.1 Business Description
                8.4.2.2 Merck KGaA Geographic Operations
                8.4.2.3 Merck KGaA Financial Information
                8.4.2.4 Merck KGaA Product Positions/Portfolio
                8.4.2.5 Merck KGaA Key Developments
        8.4.3 Zealand Pharma A/S
                8.4.3.1 Business Description
                8.4.3.2 Zealand Pharma A/S Geographic Operations
                8.4.3.3 Zealand Pharma A/S Financial Information
                8.4.3.4 Zealand Pharma A/S Product Positions/Portfolio
                8.4.3.5 Zealand Pharma A/S Key Developments
        8.4.4 OxThera
                8.4.4.1 Business Description
                8.4.4.2 OxThera Geographic Operations
                8.4.4.3 OxThera Financial Information
                8.4.4.4 OxThera Product Positions/Portfolio
                8.4.4.5 OxThera Key Developments
        8.4.5 VectivBio AG
                8.4.5.1 Business Description
                8.4.5.2 VectivBio AG Geographic Operations
                8.4.5.3 VectivBio AG Financial Information
                8.4.5.4 VectivBio AG Product Positions/Portfolio
                8.4.5.5 VectivBio AG Key Developments
        8.4.6 9 Meters Biopharma Inc.
                8.4.6.1 Business Description
                8.4.6.2 9 Meters Biopharma Inc. Geographic Operations
                8.4.6.3 9 Meters Biopharma Inc. Financial Information
                8.4.6.4 9 Meters Biopharma Inc. Product Positions/Portfolio
                8.4.6.5 9 Meters Biopharma Inc. Key Developments
        8.4.7 Nutrinia Ltd.
                8.4.7.1 Business Description
                8.4.7.2 Nutrinia Ltd. Geographic Operations
                8.4.7.3 Nutrinia Ltd. Financial Information
                8.4.7.4 Nutrinia Ltd. Product Positions/Portfolio
                8.4.7.5 Nutrinia Ltd. Key Developments
        8.4.8 Hanmi Pharm.Co. Ltd.
                8.4.8.1 Business Description
                8.4.8.2 Hanmi Pharm.Co. Ltd. Geographic Operations
                8.4.8.3 Hanmi Pharm.Co. Ltd. Financial Information
                8.4.8.4 Hanmi Pharm.Co. Ltd. Product Positions/Portfolio
                8.4.8.5 Hanmi Pharm.Co. Ltd. Key Developments
        8.4.9 Pharmascience Inc.
                8.4.9.1 Business Description
                8.4.9.2 Pharmascience Inc. Geographic Operations
                8.4.9.3 Pharmascience Inc. Financial Information
                8.4.9.4 Pharmascience Inc. Product Positions/Portfolio
                8.4.9.5 Pharmascience Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Short Bowel Syndrome Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Short Bowel Syndrome Market Revenue, By Hormone, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Short Bowel Syndrome Market Revenue, By Hospital Pharmacies, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Short Bowel Syndrome Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Short Bowel Syndrome Market Revenue, By Hormone, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Short Bowel Syndrome Market Revenue, By Hospital Pharmacies, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Short Bowel Syndrome Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Short Bowel Syndrome Market Revenue, By Hormone, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Short Bowel Syndrome Market Revenue, By Hospital Pharmacies, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Short Bowel Syndrome Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Short Bowel Syndrome Market Revenue, By Hormone, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Short Bowel Syndrome Market Revenue, By Hospital Pharmacies, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Short Bowel Syndrome Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Short Bowel Syndrome Market Revenue, By Hormone, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Short Bowel Syndrome Market Revenue, By Hospital Pharmacies, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Short Bowel Syndrome Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Short Bowel Syndrome: Market Segmentation 
FIG. 2 Global Short Bowel Syndrome Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Short Bowel Syndrome Market, By Hormone, 2019 (US$ Mn) 
FIG. 5 Global Short Bowel Syndrome Market, By Hospital Pharmacies, 2019 (US$ Mn) 
FIG. 6 Global Short Bowel Syndrome Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Short Bowel Syndrome Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Short Bowel Syndrome Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Short Bowel Syndrome Providers, 2019
FIG. 11 Global Short Bowel Syndrome Market Revenue Contribution, By Hormone, 2019 & 2028 (Value %) 
FIG. 12 Global Short Bowel Syndrome Market Revenue Contribution, By Hospital Pharmacies, 2019 & 2028 (Value %) 
FIG. 13 Global Short Bowel Syndrome Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Short Bowel Syndrome Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Short Bowel Syndrome Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Short Bowel Syndrome Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Short Bowel Syndrome Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Short Bowel Syndrome Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Short Bowel Syndrome market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Short Bowel Syndrome Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Short Bowel Syndrome Market Value, By Segment1, 2018 – 2028
TABLE  North America Short Bowel Syndrome Market Value, By Segment2, 2018 – 2028
TABLE  North America Short Bowel Syndrome Market Value, By Country, 2018 – 2028
TABLE  Europe Short Bowel Syndrome Market Value, By Segment1, 2018 – 2028
TABLE  Europe Short Bowel Syndrome Market Value, By Segment2, 2018 – 2028
TABLE  Europe Short Bowel Syndrome Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Short Bowel Syndrome Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Short Bowel Syndrome Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Short Bowel Syndrome Market Value, By Country, 2018 – 2028
TABLE  Latin America Short Bowel Syndrome Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Short Bowel Syndrome Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Short Bowel Syndrome Market Value, By Country, 2018 – 2028
TABLE  MEA Short Bowel Syndrome Market Value, By Segment1, 2018 – 2028
TABLE  MEA Short Bowel Syndrome Market Value, By Segment2, 2018 – 2028
TABLE  MEA Short Bowel Syndrome Market Value, By Country, 2018 – 2028
TABLE  Takeda Pharmaceutical Company Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck KGaA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Zealand Pharma A/S: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  OxThera: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  VectivBio AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  9 Meters Biopharma Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Nutrinia Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hanmi Pharm.Co. Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pharmascience Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Short Bowel Syndrome Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Short Bowel Syndrome Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Short Bowel Syndrome Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Short Bowel Syndrome Market, By Geography, 2019 (US$ Mn)
FIG.  Global Short Bowel Syndrome Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Short Bowel Syndrome Providers, 2016
FIG.  Global Short Bowel Syndrome Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Hormone Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Glutamine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Short Bowel Syndrome Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Hospital Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Online Sales Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Short Bowel Syndrome Market Value, 2018 – 2028, (US$ Mn)